ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,488,899, issued on Dec. 2, was assigned to OWKIN FRANCE SAS (Paris) and OWKIN INC. (New York).

"Systems and methods for determining breast cancer prognosis and associated features" was invented by Charlie Saillard (Paris), Benoit Schmauch (Paris), Victor Aubert (Paris), Aurelie Kamoun (Paris), Magali Lacroix-Triki (Paris), Ingrid Garberis (Paris), Damien Drubay (Paris) and Fabrice Andre (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "A computer implemented method and a machine learning model for predicting the likelihood that a subject having breast cancer will experience a relapse following treatment, predicting a tumor within a whole slide image,...